Mounira Kharoubi
Scientist
Post-Doctorate
Centre de Référence des Amyloses Cardiaques et ds Cardiomyopathies - Filière Cardiogène
Publications
2024
-
Broussier A, Paugam M, Liu N, Oghina S, Kharoubi M, Lafont C, Zaroui A, Galat A, Hittinger L, Teiger E, David JPhilippe, Bastuji-Garin S, Damy T. Frailty in heart failure according to the presence or absence of wild-type transthyretin cardiac amyloidosis. ESC Heart Fail. 2024.
2023
-
Kharoubi M, Bezard M, Broussier A, Galat A, Gounot R, Poullot E, Molinier-Frenkel V, Fanen P, Funalot B, Itti E, Lemonnier F, Chadha GDeep Sing, Guendouz S, Mallet S, Zaroui A, Audard V, Audureau E, Le Corvoisier P, Hittinger L, Bordeneuve VPlanté, Lefaucheur J-P, Amiot A, Béquignon E, Bartier S, Leroy V, Teiger E, Oghina S, Damy T. Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis. Front Cardiovasc Med. 2023;10:1124660.
-
Dang J, Segaux L, Moktefi A, Stehlé T, Kharoubi M, Karoui KEl, Remy P, Grimbert P, Planté-Bordeneuve V, Guendouz S, Galat A, Mallet S, Oghina S, Chadha GDeep Singh, Zaroui A, Fanen P, Canoui-Poitrine F, Damy T, Audard V. Natural course and determinants of short-term kidney function decline in hereditary transthyretin amyloidosis: a French observational study. Amyloid. 2023;30(1):38-48.
-
Damy T, Zaroui A, de Tournemire M, Kharoubi M, Gounot R, Galat A, Guendouz S, Funalot B, Itti E, Roulin L, Audard V, Fanen P, Leroy V, Poulot E, Belhadj K, Mallet S, Chadah GDeep Singh, Planté-Bordeneuve V, Gendre T, Chevalier X, Guignard S, Béquignon E, Bartier S, Folliguet T, Lemonier F, Audureau E, Tixier D, Canoui-Poitrine F, Lefaucheur J-P, Souvannanorath S, Authier F-J, Maupou S, Hittinger L, Molinier-Frenkel V, David J-P, Broussier A, Oghina S, Teiger E. Changes in amyloidosis phenotype over 11 years in a cardiac amyloidosis referral centre cohort in France. Arch Cardiovasc Dis. 2023;116(10):433-446.
-
Nicol M, Vergaro G, Damy T, Kharoubi M, Baudet M, Canuti ESofia, Aimo A, Castiglione V, Emdin M, Royer B, Harel S, Cohen-Solal A, Arnulf B, Logeart D. Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study. Front Cardiovasc Med. 2023;10:1179968.
-
Albenque G, Bezard M, Kharoubi M, Odouard S, Lunati A, Poullot E, Zaroui A, Teiger E, Hittinger L, Audard V, Karoui KEl, Funalot B, Fanen P, Damy T, Oghina S. Comparison of cardiac involvement, extracardiac manifestations and outcomes between homozygote and heterozygote transthyretin p.Val142Ile (V122I) variant in patients with hereditary transthyretin amyloidosis: a cohort study. Amyloid. 2023;30(4):407-415.
-
Bezard M, Kharoubi M, Galat A, Le Bras F, Poullot E, Molinier-Frenkel V, Fanen P, Funalot B, Moktefi A, Abulizi M, Deux J-F, Lemonnier F, Guendouz S, Chalard C, Zaroui A, Itti E, Hittinger L, Teiger E, Oghina S, Damy T. Real-Life Evaluation of an Algorithm for the Diagnosis of Cardiac Amyloidosis. Mayo Clin Proc. 2023;98(1):48-59.
2022
-
Jobbé-Duval A, Bezard M, Moutereau S, Kharoubi M, Oghina S, Zaroui A, Galat A, Chalard C, Hugon-Vallet E, Lemonnier F, Eyharts D, Poulot E, Fanen P, Funalot B, Molinier-Frenkel V, Audard V, Hittinger L, Delbarre MAntoine, Teiger E, Damy T. Prevalence and determinants of iron deficiency in cardiac amyloidosis. ESC Heart Fail. 2022;9(2):1314-1327.
-
Kharoubi M, Bodez D, Bezard M, Zaroui A, Galat A, Guendouz S, Gendre T, Hittinger L, Attias D, Mohty D, Bergoend E, Itti E, Lebras F, Hamon D, Poullot E, Molinier-Frenkel V, Lellouche N, Deux J-F, Funalot B, Fannen P, Oghina S, Arrouasse R, Lecorvoisier P, Souvannanorath S, Amiot A, Teiger E, Bougouin W, Damy T. Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survival. Amyloid. 2022;29(2):79-91.
-
Law S, Bezard M, Petrie A, Chacko L, Cohen OC, Ravichandran S, Ogunbiyi O, Kharoubi M, Ganeshananthan S, Ganeshananthan S, Gilbertson JA, Rowczenio D, Wechalekar A, Martinez-Naharro A, Lachmann HJ, Whelan CJ, Hutt DF, Hawkins PN, Damy T, Fontana M, Gillmore JD. Characteristics and natural history of early-stage cardiac transthyretin amyloidosis. Eur Heart J. 2022;43(27):2622-2632.
-
Guendouz S, Grimbert P, Radu C, Cherqui D, Salloum C, Mongardon N, Maghrebi S, Belhadj K, Le Bras F, Teiger E, Couetil J-P, Balan A, Kharoubi M, Bezard M, Oghina S, Bodez D, Hittinger L, Audard V, Planté-Bordeneuve V, de la Taille A, Bergoend E, Frenkel V, Fanen P, Leroy V, Duvoux C, Carmagnat M, Folliguet T, Damy T. Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac Amyloidosis. Transplant Direct. 2022;8(7):e1323.
-
Odouard S, Abulizi M, Kharoubi M, Oghina S, Guendouz S, Zaroui A, Teiger E, Itti E, Damy T, Galat A. Tafamidis Decreases Cardiac Uptake of Tc-HMDP in Transthyretin Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2022;15(12):2149-2151.
-
Abroud H, Beldi-Ferchiou A, Audard V, Lemonnier F, Le Bras F, Belhadj K, Moktefi A, Poullot E, Karoui KEl, Dupuis J, Maarek A, Roulin L, Delfau-Larue M-H, Oghina S, Kharoubi M, Bezard M, Zaroui A, Damy T, Molinier-Frenkel V. Evaluation of a new ELISA assay for monoclonal free-light chain detection in patients with cardiac amyloidosis. EJHaem. 2022;3(3):828-837.
-
Gonzalez-Lopez E, Escobar-Lopez L, Obici L, Saturi G, Bezard M, Saith SE, AbouEzzeddine OF, Mussinelli R, Gagliardi C, Kharoubi M, Griffin JM, Dispenzieri A, Vilches S, Perlini S, Longhi S, Oghina S, Rivas A, Grogan M, Maurer MS, Damy T, Palladini G, Rapezzi C, García-Pavía P. Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms. JACC CardioOncol. 2022;4(4):442-454.
2021
-
Bezard M, Kharoubi M, Galat A, Poullot E, Guendouz S, Fanen P, Funalot B, Moktefi A, Lefaucheur J-P, Abulizi M, Deux J-F, Gendre T, Audard V, Karoui KEl, Canoui-Poitrine F, Zaroui A, Itti E, Teiger E, Planté-Bordeneuve V, Oghina S, Damy T. Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosis. Eur J Heart Fail. 2021;23(2):264-274.
-
Kharoubi M, Bezard M, Galat A, Le Bras F, Poullot E, Molinier-Frenkel V, Fanen P, Funalot B, Moktefi A, Lefaucheur J-P, Abulizi M, Deux J-F, Lemonnier F, Guendouz S, Chalard C, Zaroui A, Audard V, Béquignon E, Bodez D, Itti E, Hittinger L, Audureau E, Teiger E, Oghina S, Damy T. History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis. ESC Heart Fail. 2021;8(6):5501-5512.
-
Kharoubi M, Roche F, Bezard M, Hupin D, Silva S, Oghina S, Chalard C, Zaroui A, Galat A, Guendouz S, Canoui-Poitrine F, Hittinger L, Teiger E, Lefaucheur J-P, Damy T. Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild-type cardiac amyloidosis. ESC Heart Fail. 2021;8(2):1656-1665.
-
Broussier A, David JPhilippe, Kharoubi M, Oghina S, Segaux L, Teiger E, Laurent M, Fromantin I, Bastuji-Garin S, Damy T. Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the Iceberg. J Clin Med. 2021;10(15).
-
Deux J-F, Nouri R, Tacher V, Zaroui A, Derbel H, Sifaoui I, Chevance V, Ridouani F, Galat A, Kharoubi M, Oghina S, Guendouz S, Audureau E, Teiger E, Kobeiter H, Damy T. Diagnostic Value of Extracellular Volume Quantification and Myocardial Perfusion Analysis at CT in Cardiac Amyloidosis. Radiology. 2021;300(2):326-335.
-
Oghina S, Bougouin W, Kharoubi M, Bonnefous L, Galat A, Guendouz S, Bezard M, Le Bras F, Deux J-F, Itti E, Moktefi A, Fanen P, Teiger E, Mohty D, Damy T, Bodez D. Echocardiographic Patterns of Left Ventricular Diastolic Function in Cardiac Amyloidosis: An Updated Evaluation. J Clin Med. 2021;10(21).
-
Oghina S, Josse C, Bezard M, Kharoubi M, Delbarre M-A, Eyharts D, Zaroui A, Guendouz S, Galat A, Hittinger L, Fanen P, Teiger E, Mouri N, Montestruc F, Damy T. Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide and High-Sensitivity Troponin T Levels in the Natural History of Transthyretin Amyloid Cardiomyopathy and Their Evolution after Tafamidis Treatment. J Clin Med. 2021;10(21).
-
Oghina S, Bougouin W, Bezard M, Kharoubi M, Komajda M, Cohen-Solal A, Mebazaa A, Damy T, Bodez D. The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials. JACC Heart Fail. 2021;9(3):169-178.
-
Bonnefous L, Kharoubi M, Bezard M, Oghina S, Le Bras F, Poullot E, Molinier-Frenkel V, Fanen P, Deux J-F, Audard V, Itti E, Damy T, Audureau E. Assessing Cardiac Amyloidosis Subtypes by Unsupervised Phenotype Clustering Analysis. J Am Coll Cardiol. 2021;78(22):2177-2192.
-
Abulizi M, Sifaoui I, Wuliya-Gariepy M, Kharoubi M, Israël J-M, Emsen B, Bodez D, Monnet A, Didierlaurent D, Tacher V, Luciani A, Damy T, Deux J-F, Itti E. F-sodium fluoride PET/MRI myocardial imaging in patients with suspected cardiac amyloidosis. J Nucl Cardiol. 2021;28(4):1586-1595.
-
Bezard M, Oghina S, Vitiello D, Kharoubi M, Kordeli E, Galat A, Zaroui A, Guendouz S, Gilles F, Shourick J, Hamon D, Audard V, Teiger E, Poullot E, Molinier-Frenkel V, Lemonnier F, Agbulut O, Le Bras F, Damy T. Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement. PLoS One. 2021;16(9):e0257189.
2020
-
Malka N, Abulizi M, Kharoubi M, Oghina S, Galat A, Le Bras F, Moktefi A, Guendouz S, Molinier-Frenkel V, Fanen P, Funalot B, Lefaucheur J-P, Blanc-Durand P, Deux J-F, Audard V, Bodez D, Itti E, Damy T. Extracardiac soft tissue uptake, evidenced on early Tc-HMDP SPECT/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value. Eur J Nucl Med Mol Imaging. 2020;47(10):2396-2406.
2019
-
Bartier S, Bodez D, Kharoubi M, Guellich A, Canoui-Poitrine F, Chatelin V, Coste A, Damy T, Béquignon E. Association between hearing loss and hereditary ATTR amyloidosis. Amyloid. 2019;26(4):234-242.
-
Bartier S, Bodez D, Kharoubi M, Canoui-Poitrine F, Chatelin V, Henrion C, Coste A, Damy T, Béquignon E. Pharyngo-laryngeal involvement in systemic amyloidosis with cardiac involvement: a prospective observational study. Amyloid. 2019;26(4):216-224.
-
Dang J, Abulizi M, Moktefi A, Karoui KEl, Deux J-F, Bodez D, Le Bras F, Belhadj K, Remy P, Issaurat P, Planté-Bordeneuve V, Molinier-Frenkel V, Fanen P, Guendouz S, Kharoubi M, Itti E, Damy T, Audard V. Renal Infarction and Its Consequences for Renal Function in Patients With Cardiac Amyloidosis. Mayo Clin Proc. 2019;94(6):961-975.
2016
-
Gellen B, Canoui-Poitrine F, Boyer L, Drouot X, Le Thuaut A, Bodez D, Covali-Noroc A, D'ortho MPia, Guendouz S, Rappeneau S, Kharoubi M, Dubois-Randé J-L, Hittinger L, Adnot S, Bastuji-Garin S, Damy T. Apnea-hypopnea and desaturations in heart failure with reduced ejection fraction: Are we aiming at the right target?. Int J Cardiol. 2016;203:1022-8.